Base editors are newer gene-editing tools that allow precise changes at the single-nucleotide level without causing double-strand DNA breaks, unlike traditional CRISPR-Cas9. Since many human genetic diseases are caused by point mutations, base editing could be a promising therapeutic approach. This question aims to explore whether base editors offer improved safety and efficiency compared to CRISPR-Cas9, especially in reducing unwanted off-target effects.